Showing results (1-10 of 62) with videos related to
Sort By:
Pageof 7
Advances in Experimental Medicine and Biology|January 5, 2013
Targeted therapy of multiple myelomaNathan G Dolloff, Giampaolo TalamoJournal of Hematology & Oncology|September 11, 2010
Prozone effect of serum IgE levels in a case of plasma cell leukemiaGiampaolo Talamo, William Castellani, Nathan G DolloffRare Tumors|October 23, 2012
Clinical features and outcomes of plasma cell leukemia: a single-institution experience in the era of novel agentsGiampaolo Talamo, Nathan G Dolloff, Kamal Sharma, et al.Clinical Lymphoma, Myeloma & Leukemia|December 16, 2010
Beyond the CRAB symptoms: a study of presenting clinical manifestations of multiple myelomaGiampaolo Talamo, Umar Farooq, Maurizio Zangari, et al.European Journal of Haematology|May 1, 2012
Effect of time to infusion of autologous stem cells (24 vs. 48 h) after high-dose melphalan in patients with multiple myelomaGiampaolo Talamo, Kevin L Rakszawski, Witold B Rybka, et al.Molecular Cancer Therapeutics|September 12, 2012
Sangivamycin-like molecule 6 exhibits potent anti-multiple myeloma activity through inhibition of cyclin-dependent kinase-9Nathan G Dolloff, Joshua E Allen, David T Dicker, et al.Cancer Biology & Therapy|November 28, 2018
Discovery platform for inhibitors of IgH gene enhancer activityNathan G DolloffAdvances in Cancer Research|June 22, 2015
Emerging Therapeutic Strategies for Overcoming Proteasome Inhibitor ResistanceNathan G DolloffCancer Research|January 20, 2007
Human bone marrow activates the Akt pathway in metastatic prostate cells through transactivation of the alpha-platelet-derived growth factor receptorNathan G Dolloff, Mike R Russell, Nick Loizos, et al.Rare Tumors|December 9, 2010
Multiple myeloma presenting as CEA-producing rectal cancerGiampaolo Talamo, Amitkumar Barochia, Maurizio Zangari, et al.Pageof 7